Fibre Extrusion Technology of Leeds, UK, has cemented its position as a world-leading supplier of melt spinning systems for biomedical applications with a further 5 systems scheduled for delivery in 2020.

FET has a long tradition in the biomedical sector, designing and supplying a range of melt spinning systems for the production of precursor materials in medical device applications. The company’s tried and tested technology and the ability to meet the precise requirements of the strongly regulated sector makes FET the standout supplier of this technology. FET has a world leading reputation for melt spinning medial grade polymers in both synthetic resorbable and non-absorbable polymers.

Managing Director Richard Slack comments: “This expertise has provided strong commercial successes for FET. In 2019 the Company delivered 4 melt spinning systems for multifilament and monofilament applications and also one turn-key synthetic resorbable suture plant. Due for delivery in 2020 are a further 4 orders, including a multi-functional system that can produce both multifilament and monofilament pre-cursor fibres. The market for this equipment is truly global with customers based in China, SE Asia, Europe and North America.”

The in-house Process Development Laboratory has enabled the optimisation of its biomedical melt spinning technology, while ongoing collaboration with biomaterial polymer suppliers has further enhanced the Company’s position. This Laboratory is at the disposal of customers for all aspects of confidential testing and evaluation, including current projects for the development and evaluation of new and absorbable polymers.

Worldwide demand for melt spinning systems has of course skyrocketed in recent months as this process is widely used for nonwovens production for medical grade masks and the FET Laboratory has been running at capacity to accommodate associated client tests and trials.

www.fetuk.com